BioCentury
ARTICLE | Clinical News

BIO-11006 Inhalation Solution: Phase II ongoing

April 27, 2009 7:00 AM UTC

BioMarck said an independent safety monitoring committee recommended continuation of the double-blind, placebo-controlled, U.S. Phase II BREATH-1 trial based on a review of safety data from the first ...